These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21436072)

  • 21. Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis.
    Girolami A; Cosi E; Ferrari S; Girolami B
    Clin Appl Thromb Hemost; 2018 Sep; 24(6):845-849. PubMed ID: 29690772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel congenital dysprothrombinemia leading to defective prothrombin maturation.
    Bafunno V; Bury L; Tiscia GL; Fierro T; Favuzzi G; Caliandro R; Sessa F; Grandone E; Margaglione M; Gresele P
    Thromb Res; 2014 Nov; 134(5):1135-41. PubMed ID: 25242243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.
    Arumugam PI; Mullins ES; Shanmukhappa SK; Monia BP; Loberg A; Shaw MA; Rizvi T; Wansapura J; Degen JL; Malik P
    Blood; 2015 Oct; 126(15):1844-55. PubMed ID: 26286849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anticoagulant thrombin mutant W215A/E217A has a collapsed primary specificity pocket.
    Pineda AO; Chen ZW; Caccia S; Cantwell AM; Savvides SN; Waksman G; Mathews FS; Di Cera E
    J Biol Chem; 2004 Sep; 279(38):39824-8. PubMed ID: 15252033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo.
    Kroh HK; Panizzi P; Tchaikovski S; Baird TR; Wei N; Krishnaswamy S; Tans G; Rosing J; Furie B; Furie BC; Bock PE
    J Biol Chem; 2011 Jul; 286(26):23345-56. PubMed ID: 21531712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WEDGE: an anticoagulant thrombin mutant produced by autoactivation.
    Wood DC; Pelc LA; Pozzi N; Wallisch M; Verbout NG; Tucker EI; Gruber A; Di Cera E
    J Thromb Haemost; 2015 Jan; 13(1):111-4. PubMed ID: 25369995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Silence Speaks, but We Do Not Listen: Synonymous c.1824C>T Gene Variant in the Last Exon of the Prothrombin Gene as a New Prothrombotic Risk Factor.
    Pruner I; Farm M; Tomic B; Gvozdenov M; Kovac M; Miljic P; Soutari NMH; Antovic A; Radojkovic D; Antovic J; Djordjevic V
    Clin Chem; 2020 Feb; 66(2):379-389. PubMed ID: 32040579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human prothrombin (MEDI8111) prevents bleeding in haemophilia A and B mice.
    Hansson KM; Lindblom A; Elg M; Lövgren A
    Haemophilia; 2016 May; 22(3):453-61. PubMed ID: 26635073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between thrombin mutant W215A/E217A and direct thrombin inhibitor.
    Tanaka KA; Gruber A; Szlam F; Bush LA; Hanson SR; Di Cera E
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):465-8. PubMed ID: 18600103
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutations in autolytic loop-2 and at Asp554 of human prothrombin that enhance protein C activation by meizothrombin.
    Koike H; Okuda D; Morita T
    J Biol Chem; 2003 Apr; 278(17):15015-22. PubMed ID: 12588872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin Arg541Trp Mutation Leads to Defective PC (Protein C) Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous Thrombosis.
    Wu X; Dai J; Xu X; Li F; Li L; Lu Y; Xu Q; Ding Q; Wu W; Wang X
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):483-494. PubMed ID: 31875702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.
    Marchetti M; Castoldi E; Spronk HM; van Oerle R; Balducci D; Barbui T; Rosing J; Ten Cate H; Falanga A
    Blood; 2008 Nov; 112(10):4061-8. PubMed ID: 18768782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical role for Gly25 in the B chain of human thrombin.
    Akhavan S; Miteva MA; Villoutreix BO; Venisse L; Peyvandi F; Mannucci PM; Guillin MC; Bezeaud A
    J Thromb Haemost; 2005 Jan; 3(1):139-45. PubMed ID: 15634277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of FII c.1787G>A (prothrombin Belgrade) mutation on prothrombin gene expression in vitro].
    Gvozdenov M; Pruner I; Tomic B; Kovac M; Radojkovic D; Djordjevic V
    Mol Biol (Mosk); 2017; 51(1):59-63. PubMed ID: 28251967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion of thrombin into an anticoagulant by protein engineering.
    Gibbs CS; Coutré SE; Tsiang M; Li WX; Jain AK; Dunn KE; Law VS; Mao CT; Matsumura SY; Mejza SJ
    Nature; 1995 Nov; 378(6555):413-6. PubMed ID: 7477382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions.
    Mosnier LO; Yang XV; Griffin JH
    J Biol Chem; 2007 Nov; 282(45):33022-33. PubMed ID: 17872949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variant.
    Bezeaud A; Elion J; Guillin MC
    Blood; 1988 Mar; 71(3):556-61. PubMed ID: 2830924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of pulmonary thromboembolism by neutrophil elastase in collagen-induced arthritis mice and effect of recombinant human soluble thrombomodulin.
    Matsuoka T; Jin E; Tachihara A; Ghazizadeh M; Nakajima A; Yoshino S; Katayama Y; Kawanami O
    Pathobiology; 2008; 75(5):295-305. PubMed ID: 18931532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.
    Rezaie AR; Esmon CT
    J Biol Chem; 1993 Sep; 268(27):19943-8. PubMed ID: 8104182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.